Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Experiment Videos

Genetic arrhythmias.

Silvia G Priori1, Marina Cerrone

  • 1Molecular Cardiology, IRCCS S. Maugeri Foundation, Pavia, Italy. spriori@fsm.it

Italian Heart Journal : Official Journal of the Italian Federation of Cardiology
|May 7, 2005
PubMed
Summary
This summary is machine-generated.

Related Concept Videos

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

Sedation Strategies, Drugs, and Protocols Used in Catheter Ablation of Atrial Fibrillation: A Focused Review.

Reviews in cardiovascular medicine·2026
Same author

J-Wave Syndromes: Reconciling the Complexity.

JACC. Clinical electrophysiology·2026
Same author

Inflammatory Hot Phases and Disease Trajectory in Desmosomal Cardiomyopathies.

Circulation·2026
Same author

Gene-based Therapies for Cardiovascular Medicine-Incorporating Molecular Medicine into Contemporary Cardiology.

The Canadian journal of cardiology·2026
Same author

Fibroblast growth factor 21 prevents catecholaminergic arrhythmias in a mouse model of PKP2 arrhythmogenic cardiomyopathy.

Heart rhythm·2026
Same author

Contemporary Perspectives on J-Wave Syndromes: An Expert Consensus Statement.

Journal of arrhythmia·2026

Genetic mutations in cardiac ion channels cause inherited arrhythmogenic disorders like long QT syndrome and Brugada syndrome, leading to sudden death. Genetic screening is crucial for diagnosing carriers and guiding personalized risk stratification and treatment.

Area of Science:

  • Cardiovascular Genetics
  • Molecular Cardiology
  • Inherited Arrhythmia Syndromes

Background:

  • Mutations in cardiac ion channel genes cause inherited arrhythmogenic disorders.
  • These disorders, including long QT syndrome, Brugada syndrome, catecholaminergic polymorphic ventricular tachycardia, and short QT syndrome, predispose young individuals to sudden cardiac death.
  • Incomplete penetrance necessitates genetic screening for accurate diagnosis in asymptomatic mutation carriers.

Purpose of the Study:

  • To present the molecular basis, clinical features, and therapeutic strategies for inherited arrhythmogenic disorders.
  • To highlight the importance of genetic screening in diagnosing and managing these conditions.
  • To explore the role of genetic heterogeneity in tailoring risk stratification and treatment.

Main Methods:

Related Experiment Videos

  • Review of molecular biology and clinical cardiology research.
  • Analysis of genetic mutations in cardiac ion channels and regulatory proteins.
  • Synthesis of clinical characteristics and therapeutic approaches for specific genetic variants.

Main Results:

  • Identified four major inherited arrhythmogenic disorders: long QT syndrome, Brugada syndrome, catecholaminergic polymorphic ventricular tachycardia, and short QT syndrome.
  • Demonstrated that genetic variants within these syndromes exhibit distinct clinical features.
  • Established the critical role of genetic screening in identifying at-risk individuals, even those without overt symptoms.

Conclusions:

  • Genetic mutations in cardiac ion channels are a significant cause of inherited arrhythmogenic disorders and sudden death.
  • Genetic screening is essential for accurate diagnosis, risk stratification, and personalized treatment of these conditions.
  • Understanding genetic heterogeneity allows for targeted therapeutic interventions and improved patient outcomes.